/ CompletedNot Applicable A Proof of Concept Study in Patients Suffering of Knee Osteoarthritis (OA) and Receiving Intra-articular (IA) Injection of Synvisc-one® to Assess the Clinical Pertinence of a New Analytical Tool of Synovial Fluid
The objective of this trial is to assess the clinical pertinence of an innovative analytical tool (SYNODIAG) to analyze the Synovial Fluid (SF) composition and guide the patient treatment in a Proof of Concept (PoC) study using OA patients receiving IA injection of SYNVISC ONE®.
100 Clinical Results associated with Pulsalys SAS
0 Patents (Medical) associated with Pulsalys SAS
100 Deals associated with Pulsalys SAS
100 Translational Medicine associated with Pulsalys SAS